Using AI to outsmart drug-resistant bacteria
Summary
DeepMind's AI tools (including Gemini) reduce the time to analyze bacterial protein structures from years to 6 minutes, and generate unexpected drug design ideas, accelerating the discovery of new antimicrobial drugs, potentially getting ahead of antibiotic resistance.
View Cached Full Text
Cached at: 05/19/26, 06:53 PM
Similar Articles
Discovering New Antibiotics with ChatGPT
AI tools like ChatGPT are shortening antibiotic discovery from years to hours through computational molecular design, addressing the global antimicrobial resistance crisis.
How AI helps scientists design the next generation of medicines
AI is accelerating biologic drug design by predicting candidate molecules and enabling multi-target therapies, with potential to cut discovery timelines by 50% and target previously undruggable diseases.
How a researcher uses Codex and ChatGPT to search for new antimicrobial molecules
A researcher uses OpenAI's Codex and ChatGPT to accelerate the discovery of new antimicrobial molecules by treating biology as information and leveraging AI to search vast datasets for functional patterns.
The biggest AI breakthrough in medicine & drug discovery
MAML is a novel multi-modal AI model that unifies understanding of chemistry, genetics, and proteins, outperforming specialized models on 11 drug discovery benchmarks, promising to accelerate pharmaceutical research and improve success rates.
@GoogleDeepMind: We want to help scientists discover their next breakthrough with AI. Gemini for Science is our new suite of experimenta…
Google DeepMind announces Gemini for Science, a suite of experimental AI tools to help scientists explore hypotheses, validate work, and unpack literature.